ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 21 filers reported holding ARMATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,390 | +163.2% | 18,130 | 0.0% | 0.01% | +133.3% |
| Q2 2023 | $20,668 | -31.7% | 18,130 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $30,277 | +34.7% | 18,130 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $22,481 | -69.6% | 18,130 | +3.3% | 0.00% | -72.7% |
| Q3 2022 | $74,000 | +8.8% | 17,550 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $68,000 | -17.1% | 17,550 | +5.1% | 0.01% | 0.0% |
| Q1 2022 | $82,000 | +10.8% | 16,700 | +23.7% | 0.01% | +12.5% |
| Q4 2021 | $74,000 | +51.0% | 13,500 | 0.0% | 0.01% | +33.3% |
| Q3 2021 | $49,000 | -9.3% | 13,500 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $54,000 | -16.9% | 13,500 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $65,000 | +71.1% | 13,500 | +6.7% | 0.01% | +80.0% |
| Q4 2020 | $38,000 | -5.0% | 12,655 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $40,000 | -20.0% | 12,655 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $50,000 | +28.2% | 12,655 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $39,000 | – | 12,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $480,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 17,550 | $74,000 | 0.01% |
| SYNOVUS FINANCIAL CORP | 47,903 | $202,000 | 0.00% |
| Edgewood Management | 100,000 | $422,000 | 0.00% |
| ROYAL BANK OF CANADA | 134 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 287,350 | $1,213,000 | 0.00% |
| UBS Group AG | 1,875 | $8,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,500 | $23,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,072 | $56,000 | 0.00% |